Procedure
3-Tesla MRI for Prostate Cancer
Recruiting1 award
Columbus, Ohio
This trial is testing whether an MRI of the prostate done with a 3 Tesla magnet and an external body coil is as good as the standard 1.5 Tesla MRI with an endorectal coil in terms of helping doctors decide which approaches to disease therapy might be best for patients.
Radiation Therapy
Motion-Corrected Cone-Beam CT for Lung Cancer
Recruiting1 award
Commack, New York
This trial is testing a new computer program that may help doctors better locate tumors in cone-beam CT scans. The effects of this program on patients and cancer treatment will be studied. Additionally, the program will be compared to radio signals in tracking markers in images.
Bacterial Extract
Oral Bacterial Extract for Wheezing
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial tests if giving Broncho-Vaxom® to high-risk infants can delay their first episode of wheezing illness. The medication is given regularly over a long period and aims to boost the immune system. The study focuses on infants aged 6-18 months who are more likely to develop asthma.
Popular Filters
Trials for Cancer Patients
Cannabinoid
Medical Cannabis for Chronic Pain
Recruiting1 awardPhase 2
Boca Raton, Florida
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Nivolumab for Esophageal Cancer
Recruiting1 awardPhase 3
Tucson, Arizona
This trial is testing if Nivolumab, a drug that helps the immune system fight cancer, can help cancer patients stay free of the disease longer. Nivolumab has been shown to improve survival in various cancers, including melanoma and esophageal cancer.
Topoisomerase I inhibitors
Lurbinectedin + Irinotecan for Cancer
Recruiting2 awardsPhase 1 & 2
Boston, Massachusetts
This trial is testing a new cancer drug, Lurbinectedin, in combination with another cancer drug, irinotecan. The trial will have two parts: first, they will test different doses of the drugs to see what is safe; then, they will expand the trial to include more people.
Trials for HIV Patients
Antiretroviral
E/C/F/TAF for HIV-1 Infection
Recruiting1 awardPhase 2 & 3
Long Beach, California
This trial tests a single pill combining four HIV medications in adolescents and children. It aims to find the right dose and ensure safety for those new to treatment and those already on it. The pill works by stopping the virus from growing and spreading.
Phase 3 Trials
Antiretroviral
E/C/F/TAF for HIV-1 Infection
Recruiting1 awardPhase 2 & 3
Long Beach, California
This trial tests a single pill combining four HIV medications in adolescents and children. It aims to find the right dose and ensure safety for those new to treatment and those already on it. The pill works by stopping the virus from growing and spreading.
Nivolumab for Esophageal Cancer
Recruiting1 awardPhase 3
Tucson, Arizona
This trial is testing if Nivolumab, a drug that helps the immune system fight cancer, can help cancer patients stay free of the disease longer. Nivolumab has been shown to improve survival in various cancers, including melanoma and esophageal cancer.
Trials With No Placebo
Cannabinoid
Medical Cannabis for Chronic Pain
Recruiting1 awardPhase 2
Boca Raton, Florida
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Platinum-based Chemotherapy
Risk-Directed Therapy for Medulloblastoma
Recruiting1 awardPhase 2
Palo Alto, California
This trial will use a new way to treat medulloblastoma, which is a cancer of the brain. The treatment will be based on the amount of leftover disease present after surgery, as well as the type of cancer cells. This will help to determine the best way to treat the cancer and improve the outcome for patients.
Antiretroviral
E/C/F/TAF for HIV-1 Infection
Recruiting1 awardPhase 2 & 3
Long Beach, California
This trial tests a single pill combining four HIV medications in adolescents and children. It aims to find the right dose and ensure safety for those new to treatment and those already on it. The pill works by stopping the virus from growing and spreading.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.